Painful acute thyroiditis following a first cure of Ipilimumab plus Nivolumab for metastatic melanoma

被引：2
|
作者：
Montaudie, Henri [1 ,2 ]
Picard, Alexandra [1 ]
Panaia-Ferrari, Patricia [3 ]
Boukari, Feriel [1 ]
Passeron, Thierry [1 ,2 ]
Sadoul, Jean-Louis [3 ]
Brucker-Davis, Francoise [3 ]
机构：
[1] Univ Hosp Nice, Archet 2 Hosp, Dept Dermatol, Nice, France
[2] INSERM, Ctr Mediterraneen Med Mol, Nice, France
[3] Cote Azur Univ, Univ Hosp Nice, Archet 2 Hosp, Dept Endocrinol Diabetol & Reprod Med, Nice, France
来源：
MELANOMA RESEARCH | 2018年 / 28卷 / 04期
关键词：
D O I：
10.1097/CMR.0000000000000460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：368 / 369
页数：2
相关论文
共 50 条
  • [21] The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab plus nivolumab vs. nivolumab in a real-world setting
    Billard, Karine
    Mortier, Laurent
    Dereure, Olivier
    Dalac, Sophie
    Montaudie, Henri
    Legoupil, Delphine
    Dutriaux, Caroline
    De Quatrebarbes, Julie
    Maubec, Eve
    Leccia, Marie-Therese
    Granel-Brocard, Florence
    Brunet-Possenti, Florence
    Arnault, Jean-Philippe
    Gaudy-Marqueste, Caroline
    Pages, Cecile
    Saiag, Philippe
    L'Orphelin, Jean-Matthieu
    Zehou, Ouidad
    Lesimple, Thierry
    Allayous, Clara
    Porcher, Raphael
    Oriano, Bastien
    Dalle, Stephane
    Lebbe, Celeste
    BRITISH JOURNAL OF DERMATOLOGY, 2025,
  • [22] Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma
    Ugurel, Selma
    Kiecker, Felix
    Froehling, Stefan
    Wetter, Axel
    Bankfalvi, Agnes
    Sucker, Antje
    Zimmer, Lisa
    Livingstone, Elisabeth
    Roesch, Alexander
    Becker, Juergen C.
    Schadendorf, Dirk
    EUROPEAN JOURNAL OF CANCER, 2017, 83 : 142 - 145
  • [23] COST-EFFECTIVENESS OF NIVOLUMAB plus IPILIMUMAB IN FIRST -LINE TREATMENT OF ADVANCED MELANOMA
    Baker, T. M.
    Paly, V. F.
    Sabater, J.
    Okoro, T.
    Kotapati, S.
    Briggs, A.
    VALUE IN HEALTH, 2016, 19 (07) : A730 - A730
  • [24] Clinical characteristics of responders to nivolumab plus ipilimumab (Nivo/Ipi) in metastatic uveal melanoma.
    Shephard, Michael Paul
    Glover, Maura
    Balmes, Gener
    Cain, Suzanne
    Vardeleon, Anna
    Mouton, Rosalind
    Posada, Liberty
    Simien, Rinata
    Hwu, Patrick
    Davies, Michael
    Yee, Cassian
    Wong, Michael
    Tawbi, Hussein
    Woodman, Scott
    Amaria, Rodabe
    Diab, Adi
    Glitza, Isabella
    Hwu, Wen-Jen
    Patel, Sapna
    CANCER RESEARCH, 2020, 80 (19) : 38 - 38
  • [25] Induction Exposure Dose of Ipilimumab and Failure of Adjuvant Nivolumab Plus Ipilimumab in Melanoma
    Augustin, Ryan C.
    Luke, Jason J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 443 - +
  • [26] Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    Lawrence, Donald
    Lezcano, Cecilia
    Wu, Xinqi
    Zhou, Jun
    Sasada, Tetsuro
    Zeng, Wanyong
    Giobbie-Hurder, Anita
    Atkins, Michael B.
    Ibrahim, Nageatte
    Friedlander, Philip
    Flaherty, Keith T.
    Murphy, George F.
    Rodig, Scott
    Velazquez, Elsa F.
    Mihm, Martin C., Jr.
    Russell, Sara
    DiPiro, Pamela J.
    Yap, Jeffrey T.
    Ramaiya, Nikhil
    van den Abbeele, Annick D.
    Gargano, Maria
    McDermott, David
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) : 632 - 642
  • [27] Ipilimumab plus temozolomide in metastatic melanoma.
    Patel, S. P.
    Bedikian, A. Y.
    Papadopoulos, N. E.
    Hwu, W.
    Kim, K. B.
    Homsi, J.
    Davies, M. A.
    Woodman, S. E.
    Radvanyi, L. G.
    Woodard, K.
    Mahoney, S.
    Hwu, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
    Patel, Sapna P.
    Sheth, Rahul A.
    Davis, Christina
    Medina, Theresa
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (08)
  • [29] COST-EFFECTIVENESS OF NIVOLUMAB PLUS IPILIMUMAB IN ADVANCED MELANOMA
    Tibet, B.
    VALUE IN HEALTH, 2018, 21 : S45 - S45
  • [30] Adjuvant nivolumab plus ipilimumab for resected stage IV melanoma
    Sullivan, Ryan Joseph
    LANCET, 2020, 395 (10236): : 1524 - 1525
12345